World first as UK launches COVID-19 vaccination programme
A 90 year-old woman in Coventry has become the first person in the UK to be given the vaccine
8th December 2020
Latest news
Calquence shows long-term efficacy and tolerability in MCL
Patients with relapsed or refractory mantle cell lymphoma (MCL) treated with AstraZeneca's Calquence remained progression free for a median of 22 months
7th December 2020
Research highlights benefit of telemedicine for stroke treatment
Around one in five stroke patients could go undiagnosed with the tests currently used by paramedics
7th December 2020
Valneva fast-tracks paediatric development of Lyme disease vaccine
Company plans phase II study launch in first quarter of 2021
7th December 2020
UK launch for Vagirux
The drug is administered intravaginally as a local oestrogen therapy for treatment of vaginal atrophy due to oestrogen deficiency.
7th December 2020
Janssen seeks EU approval for twice-yearly schizophrenia treatment
Extension application is based on results from Janssen's Route 6 study
7th December 2020
Genentech’s Gavreto scores US approval for RET thyroid cancer
Precision therapy is designed to selectively target RET alterations
4th December 2020
RPS in discussions with government to improve patient access to medicines
Follows joint letter calling for pharmacists to be able make minor prescription changes
4th December 2020
Janssen eyes US approval for EGFR-targeting NSCLC therapy
Bispecific antibody targets EGFR and MET mutated tumours
4th December 2020
PureTech launches phase II ‘long COVID’ drug trial
LYT-100 will be evaluated in patients with persistent symptoms caused by COVID-19
4th December 2020
Janssen buys rights to Hemera’s eye disease gene therapy candidate
Therapy targets CD59 protein to preserve vision in geographical atrophy patients
3rd December 2020
AbbVie partners with Frontier Medicines on protein degrader development
Partnership will seek to develop small molecules for oncology/immunology targets
3rd December 2020
DSRU plans ‘post-authorisation’ study of COVID-19 vaccines in the UK
Drug Safety Research Unit set to conduct active surveillance study on COVID-19 vaccines
3rd December 2020
Bayer establishes new cell and gene therapy platform
Platform will enable Bayer to pursue external collaborations and bolster internal capabilities
3rd December 2020
Vectura, Kinaset Therapeutics set to develop inhaled asthma drug
Companies have signed development and commercialisation agreement
2nd December 2020
